Type 2 Diabetes Trial, Recruiting NCT06532461 Sponsor: Steno Diabetes Center Copenhagen Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06532461
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 1 diabetes
  • People who have had diabetes for more than 6 months before joining the trial
  • People who are currently using a specific insulin pump system called the Medtronic 780G with its matching sensor (a CE-marked hybrid closed-loop system)
  • People who are planning to use the Medtronic 780G insulin pump system with its matching sensor
  • People who are between 7 and 18 years old at the time of joining
  • People whose body requires more than 8 units of insulin per day

Who may not be able to join:

  • People who are unable to read and understand Danish
  • People whose cognitive development may make it difficult to complete questionnaires in Danish or to participate in phone or video call contact

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jannet Svensson, Steno Diabetes Center Copenhagen

Phone: 25488355

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Steno Diabetes Center Copenhagen
Registry
ClinicalTrials.gov
Start date
20 July 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Occurence of hyperchogenicity at last two positions for infusions sets

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov